Table 1 Discovery cohort clinical and demographic characteristics
Control (n=24) | AIS (n=39) | Statistic (df) | P | |
|---|---|---|---|---|
Age (mean±s.d.) | 59.9±9.7 | 73.1±14.0 | t=−4.40 (61) | >0.001* |
Female n (%) | 14 (58.3) | 22 (56.4) | χ2=0.12 (1) | 0.731 |
NIHSS (mean±s.d.) | 0±0.0 | 5.3±6.4 | t=5.17 (38) | >0.001* |
Family history of stroke n (%) | 4 (16.7) | 15 (38.5) | χ2=7.02 (1) | 0.008* |
Hypertension n (%) | 7 (29.2) | 25 (64.1) | χ2=11.2 (1) | 0.001* |
Dyslipidaemia n (%) | 0 (0.00) | 18 (46.2) | χ2=15.5 (1) | >0.001* |
Diabetes n (%) | 2 (8.30) | 11 (28.2) | χ2=3.58 (1) | 0.058 |
Previous stroke n (%) | 2 (8.30) | 6 (15.4) | χ2=0.67 (1) | 0.414 |
Atrial fibrillation n (%) | 0 (0.00) | 6 (15.4) | χ2=4.08 (1) | 0.043* |
Myocardial infarction n (%) | 0 (0.00) | 6 (15.4) | χ2=4.08 (1) | 0.043* |
Hypertension medication n (%) | 8 (33.3) | 29 (74.4) | χ2=10.3 (1) | 0.001* |
Diabetes medication n (%) | 1 (4.20) | 7 (17.9) | χ2=2.55 (1) | 0.111 |
Cholesterol medication n (%) | 5 (20.8) | 17 (43.6) | χ2=3.39 (1) | 0.066 |
Anticoagulant or antiplatelet n (%) | 1 (4.20) | 20 (51.3) | χ2=14.9 (1) | >0.001* |
rtPA n (%) | 0 (0.00) | 9 (23.1) | χ2=6.46 (1) | 0.011* |
Current smoker n (%) | 2 (8.30) | 2 (5.13) | χ2=0.26 (1) | 0.612 |
